News
April 2012: New GHTC report finds that the US Government is the largest funder of global health R&D worldwide
A report released by the Global Health Technologies Coalition (GHTC) and Policy Cures finds that the United States government is the largest funder of global health research and development (R&D) in the world, investing $12.7 billion over the past 10 years in the creation of new vaccines, drugs, diagnostics, and other products for neglected diseases of the developing world. That funding, according to the report, helped lead to the development of more than half of the 45 new health products in the last decade that have been used to save lives around the world...read more
Read the full report 
Saving lives and creating impact: Why investing in global health research works
GHTC report launch, sample of press coverage:
March 2012: BVGH publishes new product developer landscape analysis
BVGH recently published a new report that analyzes drug and vaccine developer engagement in global health. Leveraging data from their Global Health Primer, BVGH explores the extent to which different types of organizations are participating in drug and vaccine development for a broad range of neglected tropical diseases.
Read the full report by BVGH - Developing New Drugs & Vaccines for Neglected Diseases of the Poor: The Product Developer Landscape
December 2011: Fourth annual G-FINDER survey report released
A fresh round of funding cuts from rich nations in the wake of the global financial crisis threaten the development of a new generation of lifesaving medicines and vaccines just as they are on the verge of reaching patients in the developing world. Public funding from the world’s richest nations for research and development (R&D) of new neglected disease products fell by US$125m (down 6%) in 2010, according to new data published in the fourth annual G-FINDER report. Diseases like HIV that rely heavily on public funding have been hit the hardest, with a US$70m cut in HIV R&D funding alone... read more
Read the full G-FINDER report 2011 or view G-FINDER highlights 2011
G-FINDER highlights 2011 are also available in French, Spanish, and German.
G-FINDER 2011 media release Australia
View the G-FINDER 2011 launch presentation.
What partners are saying about G-FINDER:
"Over the years G-finder has made itself the most relevant tool to acknowledge improvement on innovation. From the perspective of an Institute devoted to Global Health, G-Finder has become a daily tool of reference. Today, however, when economic resources from rich countries are scarce, it becomes not only a reference on innovation, but also a very useful guide for donors and governments to see that the good science to bridge the gap is working, and change is possible."
- Rafael Vilasanjuan, Director, Think Tank, Barcelona Institute for Global Health, IS Global – Barcelona
G-FINDER launch 2011, sample of international press coverage:
G-FINDER launch 2011, sample of Australian press coverage:
August 2011: G-FINDER Public Search Tool now available
The G-FINDER project, conducted by Policy Cures and sponsored by the Bill & Melinda Gates Foundation, is an annually updated database of global investment into neglected disease R&D. Policy Cures is now hosting the latest version of the G-FINDER Public Search Tool, which provides open access to G-FINDER survey data that is not protected by confidentiality agreements. The Public Search Tool has recently been updated with year 3 and recipient data and search results can be exported into Microsoft Excel format to support flexible analysis of the data.
June 2011: The report, “Staying the Course? Malaria Research and Development in a Time of Economic Uncertainty” released
A new analysis of progress in the global fight against malaria finds a five-fold increase in annual funding for malaria research and development (R&D) in just 16 years—increasing from US$121 million in 1993 to US$612 million in 2009, with a particularly rapid increase since 2004. The funding has generated the strongest pipeline of malaria control and prevention products in history.
The report warns, however, that even a small decline in annual funding could jeopardize this pipeline, derail development of needed products, and paradoxically also increase development costs later... read more
Read the full Malaria Research and Development Report or view the Executive Summary
May 2011: Policy Cures co-authored article selected for inclusion in WHO/PLoS Collection
For the first time the flagship report of the World Health Organization (WHO), known as The World Health Report, will focus on the necessity of research for better health. Decisions regarding healthcare have been and still are being made without a solid grounding in research evidence. In order to reinforce this message that research is critical for meeting health needs and improving outcomes the WHO is collaborating with PLoS Medicine to develop a collection with the title No Health Without Research.
The Policy Cures co-authored article Registering New Drugs for Low Income Countries: The African Challenge was independently selected for inclusion in the WHO/PLoS Collection.
